8/5/2020 8:09:11 AM
Endologix Receives CE Mark For ALTO Abdominal Stent Graft System
7/5/2020 10:49:48 PM
Endologix Says Initiated Voluntary Chapter 11 Case; Enters Into Deal With Deerfield Partners To Take Company Private
4/14/2020 4:03:19 PM
Endologix Appoints Tim Benner As Chief Commercial Officer
4/6/2020 8:10:02 AM
Endologix Sees Q1 Preliminary Revenue To Be About $28.5 Mln
3/30/2020 8:03:52 AM
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/17/2020 7:43:51 PM
Endologix Adds Jane Kiernan To Its Board Of Directors
3/16/2020 9:05:35 AM
Endologix Gets FDA Approval For Alto Abdominal Stent Graft System
2/24/2020 8:57:57 AM
Endologix Plans Debt Restructuring Addressing 2020 Maturities
2/3/2020 8:08:24 AM
Endologix Announces Inducement Grants Under NASDAQ Listing Rule
4/1/2019 7:43:21 AM
Endologix Reiterates 2019 Guidance; Announces Equity Financing Of $52 Mln
1/10/2019 8:03:14 AM
Endologix Appoints John Zehren As Chief Commercial Officer
1/7/2019 8:10:47 AM
Endologix Expects Revenue Of $34 Mln For Q4, $155.8 Mln For 2018